Zobrazeno 1 - 10
of 27
pro vyhledávání: '"L J, Andersen"'
Autor:
Mulverstedt, S, Klausen, I.C., Kanstrup, H, Knold, Jakob, L, J. Andersen, Theilade, Juliane, Yafasov, Karim Maksutovich, Jensen, J. S., Martinsen, M H, Korsgaard Thomsen, Kristian, Henriksen, Finn Lund, Schmidt, Erik Berg, Clausen, J., Egstrup, Kenneth, Heitmann, Merete
Publikováno v:
Mulverstedt, S, Klausen, I C, Kanstrup, H, Knold, J, L, J A, Theilade, J, Yafasov, K M, Jensen, J S, Martinsen, M H, Korsgaard Thomsen, K, Henriksen, F L, Schmidt, E B, Clausen, J, Egstrup, K & Heitmann, M 2019, ' Treatment of Hypercholesterolaemia with PCSK9 Inhibitors in Denmark. Assessment of real-life data; Extent and Efficacy after the first years of clinical use ', European Heart Journal, vol. 40, no. Suppl. 1, 2981 . https://doi.org/10.1093/eurheartj/ehz745.0002
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3062::4ee37d54db7fa4dadd83899526b44470
https://portal.findresearcher.sdu.dk/da/publications/e6130c06-8e8f-4fba-af2b-a987da811db0
https://portal.findresearcher.sdu.dk/da/publications/e6130c06-8e8f-4fba-af2b-a987da811db0
Autor:
S Mulverstedt, I C Klausen, H Kanstrup, J Knold, L J Andersen, J Theilade, K M Yafasov, J S Jensen, M H Martinsen, K K Thomsen, F L Henriksen, E B Schmidt, J Clausen, K Egstrup, M Heitmann
Publikováno v:
European Heart Journal. 40
Introduction Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9 I) are a new group of drugs for treatment of hypercholesterolaemia. At present there are two available drugs evolocumab and alirocumab, which lowers low-density lipoprotein
Autor:
Jakob Knold, Finn Lund Henriksen, Jan Skov Jensen, Merete Heitmann, Juliane Theilade, Erik Berg Schmidt, H Kanstrup, K. M. Yafasov, J. Clausen, S Mulverstedt, Kristian Korsgaard Thomsen, I. C. Klausen, M H Martinsen, L. J. Andersen, Kenneth Egstrup
Publikováno v:
European Heart Journal. 40
Introduction PCSK9 Inhibitors (PCSK9 I) are a new group of drugs for treatment of hyperlipidaemia. These drugs have been available in Denmark since October 2015. From the two existing major outcome studies (FOURIER and ODYSSEY OUTCOMES) it has been s
Autor:
J. Clausen, Juliane Theilade, H Kanstrup, Jan Skov Jensen, Kristian Korsgaard Thomsen, Finn Lund Henriksen, Jakob Knold, J. Bech, M H Martinsen, K. M. Yafasov, L. J. Andersen, L. H. Kobbelgaard, Kenneth Egstrup, Merete Heitmann, S Mulverstedt, I. C. Klausen
Publikováno v:
Mulverstedt, S, Klausen, I C, Martinsen, M H, Kanstrup, H, Thomsen, K K, Bech, J, Henriksen, F L, Knold, J, Andersen, L J, Kobbelgaard, L H, Theilade, J, Clausen, J, Yafasov, K M, Egstrup, K, Jensen, J S & Heitmann, M 2019, ' Treatment of Hypercholesterolaemia with Pcsk-9-Inhibitors in Denmark. Assessment of Real-Life Data; Extent and Efficacy After the First Years of Clinical Use ', Atherosclerosis, vol. 287, EAS19-0731, pp. E39-E40 . https://doi.org/10.1016/j.atherosclerosis.2019.06.114
Mulverstedt, S, Klausen, I C, Martinsen, M H, Kanstrup, H, Thomsen, K K, Bech, J, Henriksen, F L, Knold, J, Andersen, L J, Kobbelgaard, L H, Theilade, J, Clausen, J, Yafasov, K M, Egstrup, K, Jensen, J S & Heitmann, M 2019, ' Treatment of Hypercholesterolaemia With PCSK-9-Inhibitors in Denmark Assessment of Real-Life Data; Extent and Efficacy After the First Years of clinical Use ', Atherosclerosis, vol. 287, pp. E39-E40 . https://doi.org/10.1016/j.atherosclerosis.2019.06.114
Mulverstedt, S, Klausen, I C, Martinsen, M H, Kanstrup, H, Thomsen, K K, Bech, J, Henriksen, F L, Knold, J, Andersen, L J, Kobbelgaard, L H, Theilade, J, Clausen, J, Yafasov, K M, Egstrup, K, Jensen, J S & Heitmann, M 2019, ' Treatment of Hypercholesterolaemia With PCSK-9-Inhibitors in Denmark Assessment of Real-Life Data; Extent and Efficacy After the First Years of clinical Use ', Atherosclerosis, vol. 287, pp. E39-E40 . https://doi.org/10.1016/j.atherosclerosis.2019.06.114
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b172de9c59281b2091974d7ea76ee404
https://vbn.aau.dk/da/publications/2239d4f8-2438-4bf7-ba5a-dba17fa0893f
https://vbn.aau.dk/da/publications/2239d4f8-2438-4bf7-ba5a-dba17fa0893f
Autor:
S. G. Tischer, M. Storgaard, Hanne Rasmusen, Dan Eik Høfsten, Nis Høst, L. J. Andersen, Nick Mattsson, Eva Prescott
Publikováno v:
Scandinavian Journal of Medicine & Science in Sports. 26:64-73
We investigated the cardiovascular status of elite athletes in Denmark, the extent of abnormal cardiac findings – both training related and pathologic – and how participating in cardiac examination was perceived by the athletes. A standardized pr
Autor:
Johannes J. Struijk, Claus Graff, J. K. Kanters, Li Hong, Michael Christiansen, Egon Toft, Yanzong Yang, Esben Vedel-Larsen, L. J. Andersen, Fan Wang
Publikováno v:
European Heart Journal. 32:935-1118
Autor:
Møller, P., Primdahl, H., C, A. Kristensen, Andersen, E., L, J. Andersen, Overgaard, J., Johansen, Jørgen
Publikováno v:
Møller, P, Primdahl, H, C, A K, Andersen, E, L, J A, Overgaard, J & Johansen, J 2015, ' Effect of continued tobacco smoking during radiotherapy on loco-regional control for carcinoma of the larynx ', Radiotherapy & Oncology, vol. 115, PO-1129, pp. S613-S614 . https://doi.org/10.1016/S0167-8140(15)41121-1
Purpose/Objective: Tobacco smoking impose a poor prognosis on cancer patients either from reduced treatment response, new primary cancers, or other tobacco-related diseases. The effect of tobacco cessation in smokers commencing radiation treatment fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3062::638d4f84431c864470c170524e812b85
https://portal.findresearcher.sdu.dk/da/publications/2fff77a2-fab5-4e14-828f-7004c064cdb0
https://portal.findresearcher.sdu.dk/da/publications/2fff77a2-fab5-4e14-828f-7004c064cdb0
Autor:
S G, Tischer, N, Mattsson, M, Storgaard, D E, Høfsten, N B, Høst, L J, Andersen, E, Prescott, H K, Rasmusen
Publikováno v:
Scandinavian journal of medicinescience in sports. 26(1)
We investigated the cardiovascular status of elite athletes in Denmark, the extent of abnormal cardiac findings--both training related and pathologic--and how participating in cardiac examination was perceived by the athletes. A standardized protocol
Autor:
L J, Andersen, M B, Randers, P R, Hansen, T, Hornstrup, J F, Schmidt, J, Dvorak, P, Søgaard, P, Krustrup, J, Bangsbo
Publikováno v:
Scandinavian journal of medicinescience in sports. 24
We investigated the effects of 3 and 6 months of regular football training on cardiac structure and function in hypertensive men. Thirty-one untrained males with mild-to-moderate hypertension were randomized 2:1 to a football training group (n = 20)
Autor:
J F, Schmidt, P R, Hansen, T R, Andersen, L J, Andersen, T, Hornstrup, P, Krustrup, J, Bangsbo
Publikováno v:
Scandinavian journal of medicinescience in sports. 24
The study examined the effects of 1 year of football or strength training on cardiovascular function in 65- to 75-year-old men. Twenty-six untrained men (age: 68.2 ± 3.2 years) were randomized to football training (FTG; n = 9), strength training (ST